Biond Biologics: Funding, Investors & Team (Sep 2026)
Biond Biologics is a discovery and development company in the prosperous and evolving field of cancer immunotherapy and autoimmune disorders. Biond aims to translate high quality science into breakthrough therapies that will address unmet medical needs while focusing on innovative drugs. Biond is an Israeli company located at Galilee region, combining excellent science and out of the box innovation.
Biond Biologics has raised $15.0M across 1 funding round on record, the most recent a Series C of $15.0M announced in Nov 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Biond Biologics Company Profile and Key Stats
Latest funding round on record: Nov 2021.
Biond Biologics Funding Rounds
Biond Biologics Founders and Leadership Team
No contact details are on record for this team yet.
Biond Biologics Funding Compared to Other Biotechnology Startups
Biond Biologics' latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Biond Biologics in Biotechnology and Misgav
Companies Similar to Biond Biologics
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
Biond Biologics Funding FAQs
What does Biond Biologics do?
Biond Biologics is a discovery and development company in the prosperous and evolving field of cancer immunotherapy and autoimmune disorders. Biond aims to translate high quality science into breakthrough therapies that will address unmet medical needs while focusing on innovative drugs. Biond is an Israeli company located at Galilee region, combining excellent science and out of the box innovation.
How much funding has Biond Biologics raised?
Biond Biologics has raised $15.0M across 1 round on record. The most recent is a Series C of $15.0M announced in Nov 2021.
When did Biond Biologics last raise funding?
Biond Biologics' most recent funding round on record is a Series C of $15.0M, announced in Nov 2021.
Who is the CEO of Biond Biologics?
Tehila Ben-Moshe is listed as CEO at Biond Biologics.
Where is Biond Biologics headquartered?
Biond Biologics is based in Misgav, Hazafon, Israel.
How many employees does Biond Biologics have?
Biond Biologics is in the 11-50 employee band.
How does Biond Biologics' funding compare to other Biotechnology startups?
Biond Biologics' latest round of $15.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Biond Biologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biond Biologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.